Marion Mafham

Clinical Research Fellow, CTSU

Honorary Consultant Nephrologist, Oxford Kidney Unit

Marion Mafham studied medicine at the University of Edinburgh (1992-1998). In 2003, she joined the Renal Studies Group at CTSU for 3 years as a research fellow, working on the Study of Heart and Renal Protection. During this time she completed an MD thesis examining the relationship between measures of kidney function and cardiovascular risk factors and cardiovascular events. After completing her specialist training in Nephrology, she returned to CTSU in 2013, to work with Professor Jane Armitage in the Heart Studies Group. She is also an Honorary Consultant Nephrologist in the Oxford University Hospitals NHS trust.

Recent publications

Effects of n-3 Fatty Acid Supplements in Diabetes Mellitus.
Journal article

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1540 - 1550
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.
Journal article

ASCEND Study Collaborative Group None. et al, (2018), N Engl J Med, 379, 1529 - 1539
HARMONY or discord in cardiovascular outcome trials of GLP-1 receptor agonists?
Journal article

Mafham M. and Preiss D., (2018), Lancet
PCSK9 inhibition: ready for prime time in CKD?
Journal article

Mafham M. and Haynes R., (2018), Kidney Int, 93, 1267 - 1269
Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection.
Journal article

Mafham MM. et al, (2018), Nephrol Dial Transplant, 33, 257 - 264

More publications